FitFlow Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: the lowest compounded GLP-1 price with board-certified telehealth care
Price is where FitFlow scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro). Month-to-month pricing is $175/mo semaglutide and $235/mo tirzepatide, dropping to as low as $99 and $125/mo on annual prepay. A 4-step online process routes you to a board-certified provider, with US-licensed compounding pharmacies, free nationwide shipping, unlimited messaging, dose adjustments, FSA/HSA, and financing. Compounded meds are not FDA-approved; the pharmacy and state list are not published, and no LegitScript is shown.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to FitFlow
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Brightmeds
Best for: compounded or brand GLP-1 bundled with TRT and peptides for men
Editorial score · methodology
Direct Meds
Best for: listed for disclosure only — see its FDA warning and BBB complaints first
Editorial score · methodology
FitFlow at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored FitFlow
Each dimension is scored algorithmically from FitFlow’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.8/10At $99/mo, FitFlow runs about 41% below the $169 median for GLP-1 providers.
Effectiveness25%
7.8/10FitFlow offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.5/10Online intake and platform experience — ongoing clinician messaging, consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.2/10FitFlow's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.1/10Clinician messaging between visits.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this FitFlow review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $99–$134/mo across 2 dose/plan tiers — checked August 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with FitFlow
We walked FitFlow’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a 5-10 minute online visit questionnaire covering medical history, medications, and goals.
- 2A board-certified provider reviews your information within 24-48 hours and creates a plan.
- 3The prescription is fulfilled by US-licensed pharmacies and shipped to your door in discreet packaging within 5-7 business days.
- 4Ongoing care includes unlimited provider messaging, check-ins, and dosage adjustments.
- Homepage advertises tirzepatide as low as $134/mo and semaglutide as low as $99/mo before intake.
- Free expedited shipping via US-licensed pharmacies; discreet packaging.
- A Refund Policy is linked but terms are not shown on the reviewed pages.
- Advertises unlimited 24/7 support and unlimited provider messaging.
- Labs and video visit are not mentioned as requirements.
FitFlow customer support
- Phone
- +1 201-639-4659
- info@fitflowrx.com
GLP-1 medications FitFlow offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Month-to-month; drops to $145/mo (quarterly), $120/mo (6-month), or $99/mo on annual prepay. Same active ingredient as Wegovy.
Month-to-month; drops to $199/mo (quarterly), $175/mo (6-month), or $125/mo on annual prepay. Same active ingredient as Mounjaro.
Ready to get started?
Plans and promotions change often — check FitFlow's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro); month-to-month from $175/$235, or as low as $99/$125 on annual prepay
- 100% online 4-step process; board-certified provider review in 24-48 hours, with unlimited messaging and dose adjustments
- Free nationwide shipping (discreet, 5-7 days) from US-licensed compounding pharmacies
- FSA/HSA eligible with financing (Affirm, Klarna, Afterpay); month-to-month or prepay plans, cancel anytime
- Transparent 'no hidden fees' pricing; 6,000+ members; same-platform add-ons (NAD+, sermorelin, MIC+B12, glutathione, hair, sexual health)
Watch-outs
- Headline '$99/$125 a month' requires a full year prepaid upfront ($1,188 / $1,500); true month-to-month is $175 / $235
- Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- The compounding pharmacy partner is not named ('US-licensed / FDA-regulated pharmacies' only)
- State-availability list is not published (free nationwide shipping advertised, but no explicit state list)
- No LegitScript certification displayed
Is FitFlow worth it?
FitFlow built its program around one core idea: the lowest compounded GLP-1 price with board-certified telehealth care. It runs $99/month — toward the affordable end of the category, so cost isn't the reason to look elsewhere. It's a fairly plain, no-frills entry in the glp-1 providers category, without a lot of extra add-ons layered on top of the medication itself.
It is staffed by board-certified clinicians. It also takes HSA/FSA payment and offers round-the-clock messaging.
How much FitFlow actually costs
Compounded semaglutide runs $99/month and compounded tirzepatide runs $134/month.
That puts FitFlow below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
bmiMD (about $99/month) is one of the closest alternatives to weigh FitFlow against.
Medications: what FitFlow prescribes
FitFlow prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who FitFlow is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $99/month is below the roughly $169 median we track across the category.
- value being able to message a clinician between visits instead of waiting on the next scheduled one.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
FitFlow offers clinician messaging between visits, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
FitFlow earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where FitFlow scores best in our breakdown.
Ready to start with FitFlow?
Starting at $99/month. See current pricing and start your free consultation.
FitFlow might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this FitFlow review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See FitFlow's current pricing
Plans start at $99/month. Start your free consultation to check eligibility and today's price.